chronic kidney disease

Ozempic receives FDA nod for treating chronic kidney disease

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

The New York Times · 1d

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

Medscape · 19h

Ozempic Receives New Indications in Chronic Kidney Disease

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with chronic kidney disease.

Chronic Kidney Disease: Easy ways to keep your kidneys healthy, from diet tweaks to hydration tips

Taking charge of your health is one of the most powerful choices you can make, and prioritising your kidneys plays a vital ...

Medscape8d

GPs Face Challenges in Chronic Kidney Disease Screening

GPs struggle to integrate albuminuria screening for chronic kidney disease due to confusion over prescribing and interpreting ...

Healthline8d

How Chronic Kidney Disease Can Impact Your Mental Health

People with kidney disease may be at higher risk of anxiety and depression. But taking care of your mental health can have a positive effect on your outlook with kidney disease. Chronic ...

BioSpace1d

Lilly Cuts Mid-stage Relaxin Study in Chronic Kidney Disease for ‘Lack of Foreseeable Clinical Benefit’

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Ozempic receives FDA nod for treating chronic kidney disease

Related topics